在三阴性乳腺癌中HER2低表达的临床意义:回顾性多中心研究
Mahana Iwai1, Yoshiya Horimoto1, Rongrong Wu1
1Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan.
Cancer diagnosis & prognosis
|July 2, 2025
概括
人类表皮生长因子受体2 (HER2) 在三阴性乳腺癌 (TNBC) 中的低表达在新辅助化疗后没有显著改变结果. 然而,HER2-null瘤呈现出更高的增殖率,这表明了潜在的生物学区别.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 临床研究 临床研究
背景情况:
- 人类表皮生长因子受体2 (HER2) 低表达在三阴性乳腺癌 (TNBC) 的临床意义尚未确定.
- 抗体-药物结合物的出现增加了对HER2-低瘤的兴趣,促使人们调查这是否代表了TNBC内的独特的生物亚型.
研究的目的:
- 调查TNBC中HER2-低表达的临床意义.
- 为了比较HER2-低和HER2-零TNBC之间的临床病理特征,化疗反应和患者结果.
主要方法:
- 对261名接受新辅助化疗和治疗性手术的TNBC患者进行了回顾性分析.
- 在HER2-低和HER2-零组之间比较临床病理学特征,病理完整反应 (pCR) 率和生存结果.
主要成果:
- 在HER2-低和HER2-无TNBC组之间没有发现pCR率或生存结果的显著差异.
- 与HER2-低瘤相比,HER2-零瘤显示出显著更高的Ki67标记指数 (p=0.004).
- 在HER2-null瘤中观察到更高的pCR率和更差的远程无转移生存率的趋势.
结论:
- 低HER2和无HER2的TNBC组对新辅助化疗和患者整体结果的反应相似.
- 在HER2-null瘤中更高的增殖活性表明潜在的潜在生物差异需要进一步调查.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
8.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K


